[Values and preferences of patients: question pending].
作者信息
Alonso-Coello P, Solà I, García J M
出版信息
Aten Primaria. 2005 Apr 30;35(7):379. doi: 10.1157/13074300.
Abstract
摘要
相似文献
1
[Values and preferences of patients: question pending].
Aten Primaria. 2005 Apr 30;35(7):379. doi: 10.1157/13074300.
2
Patient preferences for ongoing warfarin management after receiving care by an anticoagulation management service.
Am J Health Syst Pharm. 2008 Aug 15;65(16):1498-500. doi: 10.2146/ajhp070274.
3
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Age Ageing. 2005 Jan;34(1):1-3. doi: 10.1093/ageing/afi008.
4
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.
BMC Health Serv Res. 2008 Oct 27;8:221. doi: 10.1186/1472-6963-8-221.
5
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.
6
[Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study].
Med Clin (Barc). 2016 Sep 2;147(5):192-198. doi: 10.1016/j.medcli.2016.05.024. Epub 2016 Jul 14.
7
[Quality of life of patients treated with oral anticoagulants].
Aten Primaria. 2005 Sep 15;36(4):224-5. doi: 10.1157/13078601.
8
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
Med Decis Making. 2005 Sep-Oct;25(5):548-59. doi: 10.1177/0272989X05280558.
9
Monitoring oral anticoagulants: new strategies for an emerging problem.
Intern Emerg Med. 2006;1(1):3-4. doi: 10.1007/BF02934713.
10
Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.
Int Heart J. 2018 Nov 28;59(6):1266-1274. doi: 10.1536/ihj.17-649. Epub 2018 Oct 25.
本文引用的文献
1
Evidence based medicine has come a long way.
BMJ. 2004 Oct 30;329(7473):990-1. doi: 10.1136/bmj.329.7473.990.
2
[Anticoagulants for patients with chronic auricular fibrillation: when are they indicated?].
Aten Primaria. 2004 Oct 31;34(7):374-8. doi: 10.1016/s0212-6567(04)79519-0.
3
Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep;126(3 Suppl):688S-696S. doi: 10.1378/chest.126.3_suppl.688S.
4
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep;126(3 Suppl):429S-456S. doi: 10.1378/chest.126.3_suppl.429S.
5
Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep;126(3 Suppl):174S-178S. doi: 10.1378/chest.126.3_suppl.174S.
6
Making decisions about benefits and harms of medicines.
BMJ. 2004 Jul 3;329(7456):47-50. doi: 10.1136/bmj.329.7456.47.
7
How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study.
Fam Pract. 2004 Jun;21(3):290-8. doi: 10.1093/fampra/cmh313.
8
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.
BMJ. 2001 Nov 24;323(7323):1218-22. doi: 10.1136/bmj.323.7323.1218.
Zotero 插件